IPP Bureau
Pfizer posts Q1FY22 PAT of Rs. 199.91 Cr
By IPP Bureau - July 29, 2021
The company posted net profit of Rs.124.45 crores for the period ended June 30, 2020.
Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr
By IPP Bureau - July 28, 2021
The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.
Granules India Q1FY22 consolidated net profit at Rs. 120.20 Cr
By IPP Bureau - July 28, 2021
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
Bharat Immunologicals and Biologicals Corporation Q1FY22 net profit at Rs. 1.92 Cr
By IPP Bureau - July 28, 2021
The company reported total income Rs.18.57 crores during the period ended June 30, 2020.
Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr
By IPP Bureau - July 28, 2021
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr
By IPP Bureau - July 28, 2021
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr
By IPP Bureau - July 28, 2021
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
Hugely successful vaccination roll out made possible by India-UK partnership
By IPP Bureau - July 28, 2021
The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector
Morepen to start Sputnik V Vaccine commercial production in 4-6 weeks
By IPP Bureau - July 28, 2021
The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval
Sun Pharma signs Cassiopea for license and supply agreements
By IPP Bureau - July 27, 2021
Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older
Kilitch starts injectables production at Ethiopia
By IPP Bureau - July 27, 2021
The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials
Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr
By IPP Bureau - July 27, 2021
The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.
GlaxoSmithKline delivers 19% revenue growth for Q1 FY22
By IPP Bureau - July 27, 2021
The company has decided to transfer our rights in relation to the lodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited
Alembic Pharmaceuticals Q1FY22 net slides to Rs. 164.52 Cr
By IPP Bureau - July 27, 2021
The US business faced price erosion due to increased competition.
Lasa production to commence in couple of weeks
By IPP Bureau - July 27, 2021
The company is confident of commencing production at both Mahad and Chiplun units soon
